Efficacy of THB001, a Potent and Selective Oral Small Molecule Inhibitor of Wild Type KIT Receptor Tyrosine Kinase, in a Rat Passive Cutaneous Anaphylaxis Model

Autor: Parry, Graham, Thullen, Tim, Chamberlain, Brian, Kent, Caitlin, Keaney, Gregg, Yoo, Stephen, Ray, Adrian
Zdroj: In The Journal of Allergy and Clinical Immunology February 2023 151(2) Supplement:AB51-AB51
Databáze: ScienceDirect